GLP1R and chronic kidney disease: Prior to matching, the GLP-1 RA group had higher BMI and greater ambulatory healthcare utilization, and a lower prevalence of ischemic heart diseases, chronic kidney disease, cerebrovascular diseases, and chronic obstructive pulmonary disease; these differences were attenuated post-matching (Table 1).